Fulranumab in patients with interstitial cystitis/bladder pain syndrome: observations from a randomized, double-blind, placebo-controlled study

BACKGROUND: This study was designed to evaluate the efficacy and safety of fulranumab, a fully human monoclonal antibody directed against nerve growth factor (NGF), for pain relief in patients with interstitial cystitis/bladder pain syndrome (IC/BPS). METHODS: In this multicenter, double-blind study...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Urol
Autori principali: Wang, Hao, Russell, Lucille J., Kelly, Kathleen M., Wang, Steven, Thipphawong, John
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2017
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5217311/
https://ncbi.nlm.nih.gov/pubmed/28056917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-016-0193-z
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi